The prognostic value of BCAR1 in patients with primary breast cancer.
Dorssers
Lambert C J
LC
Department of Pathology, Division of Molecular Biology, Erasmus MC Rotterdam, Rotterdam. l.dorssers@erasmusmc.nl
Grebenchtchikov
Nicolai
N
Brinkman
Arend
A
Look
Maxime P
MP
van Broekhoven
Simone P J
SP
de Jong
Danielle
D
Peters
Harry A
HA
Portengen
Henk
H
Meijer-van Gelder
Marion E
ME
Klijn
Jan G M
JG
van Tienoven
Doorlene T H
DT
Geurts-Moespot
Anneke
A
Span
Paul N
PN
Foekens
John A
JA
Sweep
Fred C G J
FC
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D017024:Chemotherapy, Adjuvant; D050719:Crk-Associated Substrate Protein; D003600:Cytosol / Q000378:metabolism; D018572:Disease-Free Survival; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D016013:Likelihood Functions; D008875:Middle Aged; D015999:Multivariate Analysis; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D011379:Prognosis; D016016:Proportional Hazards Models; D011506:Proteins / Q000235:genetics*; D012008:Recurrence; D050717:Retinoblastoma-Like Protein p130; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism
C493841:BCAR1 protein, human; D050719:Crk-Associated Substrate Protein; D017395:Plasminogen Activator Inhibitor 1; D011506:Proteins; D050717:Retinoblastoma-Like Protein p130; D014568:Urokinase-Type Plasminogen Activator